{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:00:51Z","timestamp":1790622051326,"version":"4.1.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jtho.2022.07.004","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:41:43Z","timestamp":1664584903000},"page":"1233-1234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tumor-Associated Raynaud\u2019s Phenomenon Exacerbated by Administration of Immune Checkpoint Inhibitors"],"prefix":"10.1016","volume":"17","author":[{"given":"Toshiyuki","family":"Sumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Michimata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Koshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2022.07.004_bib1","article-title":"Paraneoplastic Raynaud\u2019s phenomenon as an initial manifestation of lung cancer?","volume":"8","author":"Lokineni","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.jtho.2022.07.004_bib2","doi-asserted-by":"crossref","first-page":"e753","DOI":"10.1634\/theoncologist.2019-0666","article-title":"Late-onset immunotherapy toxicity and delayed autoantibody changes: checkpoint inhibitor-induced Raynaud\u2019s-like phenomenon","volume":"25","author":"Khan","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.jtho.2022.07.004_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s42466-020-00099-5","article-title":"Immunoglobulins to mitigate paraneoplastic Lambert Eaton myasthenic syndrome under checkpoint inhibition in Merkel cell carcinoma","volume":"2","author":"Dohrn","year":"2020","journal-title":"Neurol Res Pract"},{"key":"10.1016\/j.jtho.2022.07.004_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jpainsymman.2009.09.006","article-title":"Paraneoplastic Raynaud\u2019s phenomenon--good palliation after a multidisciplinary approach","volume":"39","author":"Schildmann","year":"2010","journal-title":"J\u00a0Pain Symptom Manag"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086422003434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086422003434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:50:38Z","timestamp":1761562238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086422003434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":4,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1556086422003434"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2022.07.004","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-Associated Raynaud\u2019s Phenomenon Exacerbated by Administration of Immune Checkpoint Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2022.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Association for the Study of Lung Cancer. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}